STRO
HEALTHCARESutro Biopharma Inc
$37.69+0.37 (+0.99%)PRE
Live · NASDAQ · May 9, Close
AI Insight
What's Moving STRO Today?
No stock-specific AI insight has been generated for STRO yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$6.74$40.25
$37.69
Fundamentals
Market Cap$624M
P/E Ratio—
EPS$-22.49
Dividend Yield—
Dividend / Share—
ROE-18.1%
Profit Margin-1.9%
Debt / Equity—
Trading
Volume149K
Avg Volume (10D)—
Shares Outstanding16.6M
STRO News
20 articles- MannKind (MNKD) Reports Q1 Loss, Misses Revenue EstimatesYahoo Finance·May 6, 2026
- Ocugen (OCGN) Reports Q1 Loss, Beats Revenue EstimatesYahoo Finance·May 5, 2026
- Citizens Lifts PT on Sutro Biopharma (STRO) on Its Pipeline and Lead ProgramYahoo Finance·May 1, 2026
- Meta downgraded, Qualcomm upgraded: Wall Street's top analyst callsYahoo Finance·Apr 30, 2026
- Here is Why Sutro Biopharma (STRO) is One of the Tiny Stocks That Are On Fire Right NowYahoo Finance·Apr 29, 2026
- Sutro Biopharma Presents Promising Preclinical Data Across its Pipeline of Next-Generation Single and Dual-Payload ADC Programs at AACR 2026GlobeNewswire Inc.·Apr 19, 2026
- Sutro Biopharma (STRO) Moves 7.4% Higher: Will This Strength Last?Yahoo Finance·Apr 8, 2026
- Arm downgraded, Arista Networks upgraded: Wall Street's top analyst callsYahoo Finance·Apr 7, 2026
- Wave Life Sciences (WVE) Surges 9.5%: Is This an Indication of Further Gains?Yahoo Finance·Apr 1, 2026
- Sutro Biopharma Reports Full Year 2025 Financial Results and Business HighlightsYahoo Finance·Mar 23, 2026
- Arcturus Therapeutics (ARCT) Reports Q4 Loss, Misses Revenue EstimatesYahoo Finance·Mar 3, 2026
- Sutro Biopharma to Participate in Upcoming Investor ConferencesYahoo Finance·Feb 25, 2026
- Sutro Biopharma Announces Participation at the 16th World ADC London SummitYahoo Finance·Feb 23, 2026
- Sutro Biopharma (STRO) Surges 11.9%: Is This an Indication of Further Gains?Yahoo Finance·Feb 11, 2026
- Sutro Biopharma Announces Pricing of $110.0 million Underwritten OfferingYahoo Finance·Feb 10, 2026
- Sutro Biopharma, Inc. (NASDAQ:STRO) has caught the attention of institutional investors who hold a sizeable 41% stakeYahoo Finance·Feb 10, 2026
- Sutro Biopharma (STRO) Soars 5.9%: Is Further Upside Left in the Stock?Yahoo Finance·Jan 22, 2026
- Sutro Biopharma to Present at the 44th Annual J.P. Morgan Healthcare ConferenceYahoo Finance·Jan 7, 2026
- Sutro Biopharma (NASDAQ:STRO) Will Have To Spend Its Cash WiselyYahoo Finance·Dec 31, 2025
- Sutro Biopharma Regains Compliance with Nasdaq Minimum Bid Price RequirementYahoo Finance·Dec 17, 2025
All 20 articles loaded
Price Data
Open$37.50
Previous Close$37.32
Day High$39.50
Day Low$37.32
52 Week High$40.25
52 Week Low$6.74
52-Week Range
$6.74$40.25
$37.69
Fundamentals
Market Cap$624M
P/E Ratio—
EPS$-22.49
Dividend Yield—
Dividend / Share—
ROE-18.1%
Profit Margin-1.9%
Debt / Equity—
Trading
Volume149K
Avg Volume (10D)—
Shares Outstanding16.6M
About Sutro Biopharma Inc
Sutro Biopharma, Inc. is a clinical stage drug discovery, development and manufacturing company. The company is headquartered in South San Francisco, California.
HEALTHCAREBIOTECHNOLOGY
Company Details
Security TypeStock
ExchangeNASDAQ
CurrencyUSD
Round Lot—
SICBIOTECHNOLOGY
CIK—
Composite FIGI—
Share Class FIGI—